Wells Fargo’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
AAP
FIB
RA
Wells Fargo's REVS Position: Q2 2026 in Review
Wells Fargo sold out of Columbia Research Enhanced Value ETF (REVS) in Q2 2026, closing a stake of 52 shares — an estimated $1.49K sold.
Wells Fargo first reported a position in REVS in Q3 2019 and held it in 3 quarters. The position peaked at $5.05M in Q4 2019. 38 funds tracked by Wall St. Rank hold REVS as of Q2 2026.
- Wells Fargo reported no remaining Columbia Research Enhanced Value ETF position as of Q2 2026 after selling out during the quarter.
- Wells Fargo sold 52 Columbia Research Enhanced Value ETF shares in Q2 2026, an estimated $1.49K.
- Wells Fargo first reported a position in Columbia Research Enhanced Value ETF in Q3 2019 and held it in 3 quarters.
- Wells Fargo's Columbia Research Enhanced Value ETF position peaked at $5.05M in Q4 2019.
- 38 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q2 2026.
Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.